Aspiriant LLC’s Fortive FTV Stock Holding History

Aspiriant LLC’s Portfolio FTV Stock Details FTV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-5,618	Closed	-$213K	–	216
2017 Q1	$213K	Sell	5,618 -919	-14%	-$33K	0.02%	199
2016 Q4	$221K	Sell	6,537 -1,760	-21%	-$58.2K	0.02%	176
2016 Q3	$266K	Buy	+8,297	New	+$266K	0.03%	166

Other funds holding FTV

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Aspiriant LLC's FTV Position: Q2 2017 in Review

Aspiriant LLC sold out of Fortive (FTV) in Q2 2017, closing a stake of 5,618 shares — an estimated $213K sold.

Aspiriant LLC first reported a position in FTV in Q3 2016 and held it in 3 quarters. The position peaked at $266K in Q3 2016. 761 funds tracked by Wall St. Rank hold FTV as of Q2 2017.

Aspiriant LLC reported no remaining Fortive position as of Q2 2017 after selling out during the quarter.
Aspiriant LLC sold 5,618 Fortive shares in Q2 2017, an estimated $213K.
Aspiriant LLC first reported a position in Fortive in Q3 2016 and held it in 3 quarters.
Aspiriant LLC's Fortive position peaked at $266K in Q3 2016.
761 funds tracked by Wall St. Rank held Fortive as of Q2 2017.

Based on Aspiriant LLC's 13F filing for Q2 2017, filed 3 Aug 2017.